Senior insider sale
Chief Development Officer at KALVISTA PHARMACEUTICALS, INC. — senior position signals high conviction
$1.05M
39.23K shares
What this filing means
YEA CHRISTOPHER plans to sell 39.23K shares of KALVISTA PHARMACEUTICALS, INC. valued at approximately $1.05M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/27/2026ACC: 0001950047-26-005173
Officer· Chief Development Officer
Since Sep 2018
39.23K
Shares to sell
$1.05M
Approx. market value
33.80K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
5/27/2026
33.80KTotal acquired33.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/27/2026 | Stock Option Exercise Cash | 33.80K | — |
| Total | 33.80K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.97K
Market value
$52.6K
5/26/2026
—Completed
Units to sell
2.36K
Market value
$63.2K
5/22/2026
—Completed
Units to sell
1.11K
Market value
$29.7K
5/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
33.80K
Market value
$905.2K
5/27/2026
Total
Units
39.23K
Value
$1.05M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/26/2026 | 1.97K | $52.6K | — | Completed |
5/22/2026 | 2.36K | $63.2K | — | Completed |
5/18/2026 | 1.11K | $29.7K | — | Completed |
| Planned — Approximate Date | ||||
5/27/2026 | 33.80K | $905.2K | NASDAQ | Planned |
| Total | 39.23K | $1.05M | ||